beta-lactamase inhibition and in vitro activity of sulbactam and sulbactam/cefoperazone

被引:71
作者
Williams, JD
机构
[1] Department of Medical Microbiology, London Hospital, Medical College, London
[2] Department of Medical Microbiology, London Hospital Medical College, University of London, London E1 2AD, Turner Street
关键词
D O I
10.1093/clinids/24.3.494
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
beta-Lactamase inhibitors such as sulbactam are beta-lactam compounds that have low antimicrobial activity but are able to inhibit enzymes (beta-lactamases) that destroy beta-lactam antibiotics like penicillins and cephalosporins. The main activity of beta-lactamase inhibitors is directed against plasmid-mediated transferable enzymes and various extended-spectrum enzymes. Sulbactam is also active against some of the fixed chromosomally mediated enzymes produced by gram-negative bacteria and is active against Bacteroides and Acinetobacter species. Cefoperazone, a third-generation cephalosporin, is active against a wide range of gram-positive and gram-negative bacteria, including Enterobacteriaceae and Pseudomonas species. However, transferable beta-lactamases are now produced by numerous gram-negative organisms, mitigating the effectiveness of therapy with this agent. Chromosomally mediated enzymes are less common but can be induced in some strains of Klebsiella, Enterobacter, and Serratia species. The full potential of cefoperazone against Enterobacteriaceae and Pseudomonas species is restored by the addition of sulbactam; this addition extends cefoperazone's spectrum of activity to include Bacteroides and Acinetobacter species.
引用
收藏
页码:494 / 497
页数:4
相关论文
共 7 条
[1]   INVITRO ACTIVITIES OF CEFOPERAZONE AND SULBACTAM SINGLY AND IN COMBINATION AGAINST CEFOPERAZONE-RESISTANT MEMBERS OF THE FAMILY ENTEROBACTERIACEAE AND NONFERMENTERS [J].
FASS, RJ ;
GREGORY, WW ;
DAMATO, RF ;
MATSEN, JM ;
WRIGHT, DN ;
YOUNG, LS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (11) :2256-2259
[2]   MORE EXTENDED-SPECTRUM BETA-LACTAMASES [J].
JACOBY, GA ;
MEDEIROS, AA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (09) :1697-1704
[3]  
LABIA R, 1986, REV INFECT DIS, V8, pS496
[4]   BETA-LACTAMASES IN LABORATORY AND CLINICAL RESISTANCE [J].
LIVERMORE, DM .
CLINICAL MICROBIOLOGY REVIEWS, 1995, 8 (04) :557-&
[6]  
WHITAKER S, 1983, P 13 INT C CHEM VIEN, P51
[7]   MECHANISMS OF BETA-LACTAM RESISTANCE IN BRITISH ISOLATES OF PSEUDOMONAS-AERUGINOSA [J].
WILLIAMS, RJ ;
LIVERMORE, DM ;
LINDRIDGE, MA ;
SAID, AA ;
WILLIAMS, JD .
JOURNAL OF MEDICAL MICROBIOLOGY, 1984, 17 (03) :283-293